annual EBIT:
-$104.55M-$21.02M(-25.17%)Summary
- As of today (August 20, 2025), ELVN annual earnings before interest & taxes is -$104.55 million, with the most recent change of -$21.02 million (-25.17%) on December 31, 2024.
- During the last 3 years, ELVN annual EBIT has fallen by -$79.79 million (-322.24%).
- ELVN annual EBIT is now -1074.10% below its all-time high of -$8.90 million, reached on December 1, 2017.
Performance
ELVN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$28.58M+$3.11M(+9.81%)Summary
- As of today (August 20, 2025), ELVN quarterly earnings before interest & taxes is -$28.58 million, with the most recent change of +$3.11 million (+9.81%) on June 30, 2025.
- Over the past year, ELVN quarterly EBIT has dropped by -$3.98 million (-16.18%).
- ELVN quarterly EBIT is now -777.62% below its all-time high of -$3.26 million, reached on December 31, 2022.
Performance
ELVN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$114.24M-$3.98M(-3.61%)Summary
- As of today (August 20, 2025), ELVN TTM earnings before interest & taxes is -$114.24 million, with the most recent change of -$3.98 million (-3.61%) on June 30, 2025.
- Over the past year, ELVN TTM EBIT has dropped by -$16.67 million (-17.09%).
- ELVN TTM EBIT is now -1560.00% below its all-time high of -$6.88 million, reached on September 1, 2019.
Performance
ELVN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELVN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.2% | -16.2% | -17.1% |
| 3 y3 years | -322.2% | -217.0% | -150.1% |
| 5 y5 years | -333.6% | -177.5% | -365.6% |
ELVN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -322.2% | at low | -777.6% | +9.8% | -258.3% | at low |
| 5 y | 5-year | -333.6% | at low | -777.6% | +9.8% | -365.6% | at low |
| alltime | all time | -1074.1% | at low | -777.6% | +9.8% | -1560.0% | at low |
ELVN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$28.58M(-9.8%) | -$114.24M(+3.6%) |
| Mar 2025 | - | -$31.69M(+17.8%) | -$110.26M(+5.5%) |
| Dec 2024 | -$104.55M(+25.2%) | -$26.90M(-0.6%) | -$104.55M(+4.2%) |
| Sep 2024 | - | -$27.07M(+10.0%) | -$100.39M(+2.9%) |
| Jun 2024 | - | -$24.60M(-5.3%) | -$97.57M(+4.8%) |
| Mar 2024 | - | -$25.99M(+14.3%) | -$93.10M(+11.5%) |
| Dec 2023 | -$83.53M(+143.7%) | -$22.73M(-6.3%) | -$83.53M(+30.4%) |
| Sep 2023 | - | -$24.25M(+20.4%) | -$64.06M(+26.2%) |
| Jun 2023 | - | -$20.13M(+22.6%) | -$50.74M(+28.1%) |
| Mar 2023 | - | -$16.42M(+404.1%) | -$39.63M(+24.3%) |
| Dec 2022 | -$34.27M | -$3.26M(-70.2%) | -$31.89M(-25.8%) |
| Sep 2022 | - | -$10.93M(+21.3%) | -$42.96M(-6.0%) |
| Jun 2022 | - | -$9.02M(+3.9%) | -$45.69M(-8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.68M(-39.5%) | -$49.84M(-3.1%) |
| Dec 2021 | -$24.76M(-40.6%) | - | - |
| Dec 2021 | - | -$14.33M(+4.9%) | -$51.44M(+5.7%) |
| Sep 2021 | - | -$13.66M(+3.7%) | -$48.66M(+2.5%) |
| Jun 2021 | - | -$13.17M(+28.1%) | -$47.49M(+6.4%) |
| Mar 2021 | - | -$10.28M(-11.0%) | -$44.63M(+7.0%) |
| Dec 2020 | -$41.70M(+72.9%) | -$11.55M(-7.6%) | -$41.70M(+38.3%) |
| Sep 2020 | - | -$12.49M(+21.3%) | -$30.15M(+22.9%) |
| Jun 2020 | - | -$10.30M(+40.1%) | -$24.54M(+72.4%) |
| Mar 2020 | - | -$7.35M(+6.8%) | -$14.23M(+106.8%) |
| Dec 2019 | -$24.12M(+125.9%) | - | - |
| Sep 2019 | - | -$6.88M | -$6.88M |
| Dec 2018 | -$10.68M(+19.9%) | - | - |
| Dec 2017 | -$8.90M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
What is Enliven Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of ELVN is -$104.55M
What is the all time high annual EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$8.90M
What is Enliven Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, ELVN annual earnings before interest & taxes has changed by -$21.02M (-25.17%)
What is Enliven Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ELVN is -$28.58M
What is the all time high quarterly EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$3.26M
What is Enliven Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, ELVN quarterly earnings before interest & taxes has changed by -$3.98M (-16.18%)
What is Enliven Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ELVN is -$114.24M
What is the all time high TTM EBIT for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$6.88M
What is Enliven Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, ELVN TTM earnings before interest & taxes has changed by -$16.67M (-17.09%)